Knocking down of miR‐195 may affect the expression of relative ion channel protein Cavβ1, Kir2.1 and Kv4.3, which means that miR‐195 is expected to provide a therapeutic target to treat cardiac hypertrophy, arrhythmia and delay of sudden cardiac death. Here, KCNJ2 is linked to cardiac hypertrophy.